Hudson Bay Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.32M Buy
130,000
+19,280
+17% +$641K 0.01% 413
2025
Q1
$3.24M Buy
110,720
+720
+0.7% +$21.1K 0.01% 432
2024
Q4
$3.61M Buy
110,000
+50,000
+83% +$1.64M 0.01% 414
2024
Q3
$2.67M Sell
60,000
-55,000
-48% -$2.44M 0.01% 395
2024
Q2
$4.96M Sell
115,000
-292,500
-72% -$12.6M 0.02% 304
2024
Q1
$11.9M Sell
407,500
-82,500
-17% -$2.41M 0.07% 123
2023
Q4
$10.9M Buy
490,000
+220,000
+81% +$4.9M 0.07% 140
2023
Q3
$6.68M Buy
270,000
+10,000
+4% +$248K 0.05% 195
2023
Q2
$7.36M Sell
260,000
-10,000
-4% -$283K 0.05% 185
2023
Q1
$6.2M Buy
270,000
+60,000
+29% +$1.38M 0.05% 230
2022
Q4
$5.9M Buy
210,000
+30,000
+17% +$842K 0.06% 288
2022
Q3
$5.09M Sell
180,000
-163,500
-48% -$4.62M 0.05% 372
2022
Q2
$7.62M Buy
343,500
+118,500
+53% +$2.63M 0.06% 231
2022
Q1
$6.55M Buy
225,000
+25,000
+13% +$728K 0.09% 256
2021
Q4
$6.57M Buy
200,000
+125,000
+167% +$4.11M 0.07% 239
2021
Q3
$3.46M Buy
75,000
+20,000
+36% +$923K 0.05% 462
2021
Q2
$3.03M Sell
55,000
-30,000
-35% -$1.65M 0.04% 484
2021
Q1
$4.39M Sell
85,000
-95,088
-53% -$4.91M 0.05% 332
2020
Q4
$7.8M Buy
180,088
+42,588
+31% +$1.85M 0.08% 140
2020
Q3
$4.81M Buy
137,500
+102,500
+293% +$3.59M 0.07% 228
2020
Q2
$1.87M Buy
+35,000
New +$1.87M 0.03% 312
2020
Q1
Sell
-70,000
Closed -$3.34M 479
2019
Q4
$3.34M Buy
70,000
+40,000
+133% +$1.91M 0.07% 213
2019
Q3
$972K Buy
+30,000
New +$972K 0.03% 300
2019
Q2
Sell
-15,000
Closed -$1.01M 368
2019
Q1
$1.01M Buy
+15,000
New +$1.01M 0.01% 323